Dupilumab T13666
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Dupilumab (RegN-668) can inhibit IL-4 and IL-13 signaling pathways and significantly improve moderate to severe atopic dermatitis.It is a human monoclonal antibody (IL-4r-inhibitor) that completely inhibits il-4 receptors.
CAS nr:
1190264-60-8
Purity:
98%
Molecular Weight:
SMILES:
Formula:
Pathway:
Immunology/Inflammation
Target:
IL Receptor
